Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27154,124,2.04 [1.49-2.80],9.128520254470824e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27922,206,1.44 [1.08-1.91],0.0121339534617883
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27636,1375,1.19 [1.06-1.34],0.0029017302801002
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27949,481,1.16 [0.95-1.42],0.1387258931784185
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27079,3587,1.13 [1.05-1.22],0.0015351324373617
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27314,2948,1.23 [1.14-1.33],3.16913623327287e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27654,1402,1.17 [1.04-1.32],0.0075505357359607
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27843,93,1.35 [0.88-2.08],0.1683113828355421
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26053,843,1.22 [1.05-1.42],0.0080030398478269
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25188,981,1.38 [1.20-1.57],2.858362005827852e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25211,264,1.44 [1.12-1.85],0.0049300876575598
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19616,1715,1.16 [1.04-1.29],0.0066709955042958
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24976,383,1.09 [0.86-1.37],0.4699135907144439
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27886,1634,1.16 [1.04-1.30],0.0060241559244293
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,28015,547,1.10 [0.91-1.33],0.3379192006193215
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27238,977,1.20 [1.05-1.38],0.0091670310741909
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27960,930,1.25 [1.09-1.43],0.0018454584721665
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26458,206,1.45 [1.09-1.93],0.0099980368346789
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28078,47,1.53 [0.86-2.73],0.1463146911405616
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27845,815,1.21 [1.04-1.41],0.0119009149367279
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27832,82,1.13 [0.69-1.83],0.635157371080777
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27977,197,1.09 [0.79-1.49],0.6062098790214543
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27958,178,1.02 [0.73-1.43],0.9140313991753456
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26614,353,1.26 [1.01-1.59],0.0437763163276582
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26533,272,1.02 [0.78-1.35],0.8600047394159446
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26384,132,1.14 [0.77-1.68],0.5061789973219589
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28054,36,2.03 [1.09-3.78],0.0253102282430022
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28001,160,0.83 [0.57-1.21],0.3386507991065887
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,27888,47,1.30 [0.70-2.40],0.4058208257389065
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27920,79,0.62 [0.36-1.07],0.0882399217235449
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,27801,246,0.92 [0.68-1.23],0.5537882518079578
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27972,71,0.88 [0.51-1.53],0.6456618814205138
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27968,72,0.81 [0.47-1.41],0.4534084893269349
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27783,1248,1.11 [0.98-1.26],0.1016225621871162
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of meninges,28050,83,0.94 [0.57-1.56],0.8152826304213322
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28010,67,1.27 [0.75-2.13],0.3780206229515028
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28044,137,1.02 [0.69-1.50],0.9179161706795376
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of ovary,27992,181,1.00 [0.71-1.40],0.9986631179458704
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28056,284,1.14 [0.88-1.48],0.309171753874664
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,28063,254,0.98 [0.73-1.30],0.8821797537757926
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27988,66,1.24 [0.73-2.11],0.426692358078479
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,28059,158,1.10 [0.77-1.56],0.6049830209212709
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,28019,287,1.18 [0.92-1.53],0.1945554640804888
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27970,504,1.03 [0.84-1.26],0.765807362956131
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28058,302,1.08 [0.84-1.40],0.5443584576488683
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Carcinoma in situ of breast,22764,139,1.07 [0.73-1.56],0.7244116761225797
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22856,169,1.14 [0.82-1.60],0.4324316025531923
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22835,33,1.05 [0.48-2.28],0.9036527946557708
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22871,69,0.69 [0.38-1.25],0.221912010339521
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28008,139,0.96 [0.65-1.41],0.8298733092120102
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",28009,137,0.98 [0.66-1.45],0.9236036637818382
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,27067,598,0.90 [0.75-1.09],0.2932446055375957
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,20139,320,1.03 [0.80-1.32],0.8397494570196284
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lymphoid leukaemia,22840,38,0.95 [0.45-2.00],0.8833396541609198
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22982,180,1.21 [0.88-1.67],0.2502308407072061
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22918,116,1.22 [0.82-1.81],0.3384347776985303
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22992,190,1.36 [1.01-1.83],0.0439260371823356
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22873,71,1.83 [1.19-2.82],0.0056826289505676
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22876,74,1.30 [0.80-2.12],0.288221473411383
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22860,58,1.43 [0.85-2.43],0.1804207760147076
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22946,144,0.92 [0.63-1.36],0.679422778634547
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22906,104,0.94 [0.60-1.48],0.7788623691598981
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22888,86,0.72 [0.43-1.22],0.2279486755593332
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22845,43,1.49 [0.81-2.76],0.2018661255807485
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22885,83,0.61 [0.36-1.06],0.0802672197029248
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,27811,236,1.17 [0.88-1.56],0.2726584041579233
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,28030,82,1.25 [0.78-2.01],0.355780139179407
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanoma in situ,22837,90,0.92 [0.56-1.50],0.7329103761519757
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22886,84,0.69 [0.40-1.18],0.1712564703398613
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22959,157,0.89 [0.61-1.29],0.5388458706183838
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",23035,233,1.03 [0.77-1.37],0.8479550645085139
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22899,97,0.70 [0.43-1.15],0.1600036271914662
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,27847,171,0.80 [0.56-1.15],0.2353517357414591
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23762,960,0.98 [0.84-1.14],0.7802225001582993
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23803,1001,0.98 [0.85-1.14],0.817990289712041
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27768,382,1.03 [0.82-1.29],0.8129150001035284
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26000,105,1.82 [1.26-2.63],0.0013468065809685
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27456,70,1.73 [1.10-2.73],0.0172834939775317
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27035,3046,1.15 [1.06-1.24],0.0008892316641083
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26390,36,1.47 [0.74-2.95],0.2718420475654629
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27662,46,1.77 [1.01-3.10],0.0479806560879077
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27475,1580,1.18 [1.06-1.32],0.002930333719283
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27475,1580,1.18 [1.06-1.32],0.002930333719283
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25967,72,1.91 [1.23-2.97],0.003695825834385
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27657,1303,1.29 [1.15-1.45],2.1880082389169326e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27739,123,1.36 [0.93-1.98],0.1105027930171856
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27436,50,1.44 [0.82-2.55],0.2075913595645491
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27444,58,1.10 [0.61-1.97],0.754411150689975
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27857,241,1.69 [1.32-2.17],2.981402421065232e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27962,62,0.73 [0.40-1.34],0.3040116641837105
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27821,205,1.75 [1.35-2.28],3.195998934095108e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26492,138,0.89 [0.60-1.33],0.5728593913071178
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22598,260,2.00 [1.61-2.49],3.8209038567401047e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26618,71,0.71 [0.40-1.23],0.2220687367733319
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26613,66,1.38 [0.84-2.27],0.2041167015753554
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22391,53,1.11 [0.60-2.05],0.7471387748000133
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25739,73,1.22 [0.74-2.02],0.4357606952509968
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25373,253,1.07 [0.81-1.42],0.6368191699601642
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27631,522,1.19 [0.98-1.44],0.0775217929019884
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27401,292,1.15 [0.88-1.49],0.3067586709420162
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27197,88,1.54 [1.00-2.36],0.0516652969709927
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27666,2000,0.85 [0.77-0.95],0.0028623744968994
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24834,1948,0.85 [0.76-0.94],0.0019638704419442
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22398,60,0.58 [0.30-1.11],0.099584924527571
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24897,121,0.90 [0.59-1.38],0.6319931461620981
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22628,290,0.97 [0.73-1.27],0.8018832998930921
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22386,48,0.50 [0.24-1.04],0.0652975653802865
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25564,3226,0.95 [0.88-1.03],0.2484990521990076
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22540,202,1.27 [0.93-1.72],0.1287170806632058
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22882,544,0.99 [0.81-1.21],0.9465544681845636
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27972,378,0.98 [0.77-1.24],0.8517354661500143
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27781,187,0.98 [0.71-1.37],0.9219911833749193
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22439,101,0.77 [0.48-1.25],0.2937871619267755
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22394,56,1.42 [0.82-2.47],0.2137603375911796
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27164,2388,0.94 [0.86-1.04],0.2334042099691328
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22548,210,1.85 [1.43-2.38],2.0019646817821063e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22556,218,1.58 [1.21-2.07],0.0008111315876478
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22883,545,0.93 [0.76-1.13],0.4576060808032142
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22432,94,1.40 [0.91-2.16],0.1275708218082157
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27771,177,1.02 [0.72-1.43],0.9268023390082034
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22980,642,1.20 [1.01-1.43],0.0426383093260327
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22912,574,0.94 [0.77-1.14],0.513901561575309
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25192,72,1.35 [0.83-2.21],0.2295247299719081
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27148,4810,1.02 [0.96-1.09],0.4970680425339108
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24855,79,1.32 [0.82-2.14],0.255169639812091
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24865,89,0.86 [0.52-1.42],0.5575916586075761
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27874,2137,0.95 [0.86-1.04],0.2596927756518821
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27880,2137,0.95 [0.86-1.04],0.2551105682290808
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24858,82,1.06 [0.64-1.74],0.8290000481310622
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27655,1630,0.87 [0.78-0.98],0.0190712030467089
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23893,1555,1.27 [1.14-1.41],2.141358637894276e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28063,188,1.94 [1.50-2.51],4.661747491251888e-07
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27167,58,1.32 [0.75-2.31],0.3363637183644236
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26159,134,1.24 [0.86-1.79],0.2584316618697426
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26228,203,0.92 [0.66-1.27],0.6053662987976799
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22611,273,1.17 [0.89-1.53],0.2620565271172357
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26201,144,1.58 [1.13-2.19],0.0067629148610906
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1751,50,1.49 [0.90-2.45],0.1187042616107822
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1864,187,1.05 [0.78-1.42],0.7388396029052606
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26083,26,1.84 [0.93-3.63],0.0805815693688875
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1732,32,1.08 [0.52-2.22],0.8399217954940975
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27577,1520,1.38 [1.24-1.53],3.193032771832229e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27456,347,1.21 [0.95-1.53],0.1156282134596378
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25617,497,1.28 [1.05-1.55],0.014217580871361
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23081,743,1.32 [1.13-1.55],0.0004232206372332
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27974,235,1.03 [0.77-1.38],0.8303627283149025
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27038,55,1.42 [0.82-2.46],0.2088736787962608
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,26508,901,0.95 [0.81-1.10],0.4851128134331374
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27082,99,1.06 [0.68-1.66],0.7966140900320406
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27018,35,1.63 [0.86-3.09],0.1329230077016304
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27138,155,1.13 [0.80-1.60],0.488853648921414
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18240,1512,1.37 [1.22-1.52],3.0967584610860206e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,AV-block,24585,249,1.68 [1.30-2.16],5.924588755334164e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28034,311,1.31 [1.03-1.66],0.0264369189355373
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16860,132,1.69 [1.20-2.37],0.0027253451423524
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24476,140,1.77 [1.28-2.45],0.0005795251607225
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24418,82,1.51 [0.96-2.38],0.0737720380366519
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28073,35,0.75 [0.34-1.63],0.4673150768265882
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,25087,751,1.49 [1.28-1.73],2.3634026262204962e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27140,1545,1.11 [0.99-1.25],0.0639952837459814
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25236,7439,1.02 [0.97-1.08],0.4571341275624881
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26523,250,1.02 [0.77-1.37],0.8717146663086217
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Endocarditis,24399,63,1.84 [1.15-2.97],0.0118173846739733
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27977,879,1.63 [1.43-1.85],2.659764110681397e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,25876,6288,0.97 [0.91-1.03],0.2925112341398455
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25889,6301,0.97 [0.91-1.03],0.3015637911365511
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27961,42,5.45 [3.91-7.59],1.2037797106201889e-23
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19755,167,2.64 [2.09-3.33],3.643172580141047e-16
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19694,106,1.48 [1.00-2.20],0.0487535449950752
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,27933,1130,1.15 [1.01-1.31],0.0354299121213976
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27300,97,1.02 [0.64-1.64],0.9242894776710108
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27340,1733,1.09 [0.98-1.21],0.1163143368279834
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27752,467,1.09 [0.88-1.34],0.4413924642961679
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24643,307,1.28 [1.00-1.64],0.052448692240072
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27848,620,1.13 [0.95-1.35],0.1629444024934049
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26105,498,1.07 [0.87-1.31],0.5229069643992311
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28051,90,0.82 [0.50-1.36],0.4527601342256734
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28071,246,0.99 [0.74-1.32],0.9402423413844206
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26310,37,3.82 [2.57-5.68],3.2973687805038305e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,27044,61,1.62 [0.98-2.69],0.0607564705373965
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24701,365,1.61 [1.31-1.99],8.194841534986611e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27051,68,0.98 [0.57-1.69],0.9412038545223678
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27181,198,1.38 [1.02-1.85],0.0343279726688378
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24498,162,1.24 [0.88-1.75],0.2209098399498147
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26371,98,1.37 [0.90-2.08],0.1380588073750481
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26319,46,1.74 [0.99-3.07],0.0551678028014655
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26792,40,1.14 [0.56-2.30],0.7226316264751866
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26443,170,1.45 [1.07-1.96],0.0158901816929812
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25164,828,1.37 [1.18-1.58],2.679893982636651e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26847,44,3.61 [2.45-5.30],7.317407536058015e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27497,514,1.00 [0.81-1.22],0.9703989193687032
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27482,328,2.09 [1.73-2.53],4.4580623566607643e-14
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27315,563,1.14 [0.95-1.38],0.1654639722785529
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,17025,297,1.51 [1.19-1.93],0.0007784380559782
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27249,280,1.31 [1.02-1.68],0.0340049694408235
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26605,332,1.07 [0.84-1.37],0.5859655968383827
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27614,460,1.05 [0.85-1.29],0.6655035287642925
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27999,604,1.59 [1.35-1.86],1.3300241202869034e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24563,227,1.63 [1.25-2.13],0.0003533191273386
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27473,319,2.09 [1.72-2.53],1.1087387454154733e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26917,165,1.35 [0.98-1.87],0.0685363413533871
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27745,542,1.09 [0.90-1.33],0.362178183585667
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27719,590,1.09 [0.91-1.32],0.3383704738805507
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27265,72,0.86 [0.49-1.50],0.5955315214307553
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27030,47,1.56 [0.87-2.79],0.1339341919234599
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27510,225,1.08 [0.80-1.45],0.6326868244017365
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27433,205,1.01 [0.74-1.38],0.96184002302655
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,26743,470,1.55 [1.29-1.86],2.8962562022478133e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26996,98,1.23 [0.79-1.90],0.3596433247597934
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27858,723,1.05 [0.89-1.24],0.5347897891580617
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28032,224,1.41 [1.08-1.85],0.0120442033816037
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24924,1902,0.89 [0.80-0.99],0.0298981291099771
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,27449,4427,0.96 [0.90-1.03],0.2525744914777119
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28000,267,1.23 [0.95-1.59],0.118191210028446
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25044,2022,0.86 [0.78-0.96],0.0057886189701519
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23117,95,1.42 [0.93-2.16],0.1029118676439875
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,27653,1224,1.06 [0.93-1.20],0.3795110918912345
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24435,1413,1.07 [0.95-1.20],0.2510030727114977
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Vascular dementia,27563,104,1.41 [0.94-2.12],0.0960980189235532
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,28077,365,1.14 [0.91-1.44],0.254916520914892
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",19142,59,1.16 [0.65-2.04],0.6187955592072282
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Bell's palsy,25860,88,1.26 [0.80-1.97],0.3215215797372165
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26420,648,0.93 [0.78-1.12],0.4492251026121538
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,27662,226,1.25 [0.94-1.65],0.1232486184461074
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28003,286,0.87 [0.66-1.15],0.3222146545930163
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27581,40,2.27 [1.34-3.86],0.0023774081987122
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28063,47,0.88 [0.45-1.74],0.7225663475511347
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27492,56,1.28 [0.73-2.27],0.3900691510387861
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,26543,287,1.18 [0.91-1.53],0.2125810933841317
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27647,1391,0.96 [0.85-1.08],0.4806344245690794
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28027,527,0.95 [0.78-1.17],0.6425964481532973
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27425,2974,1.11 [1.02-1.21],0.0111923134369344
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27699,48,1.50 [0.83-2.69],0.1776024884498471
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,27945,228,0.89 [0.65-1.21],0.4550552472102639
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,27504,68,1.07 [0.62-1.85],0.8089228501472983
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28057,79,1.18 [0.72-1.93],0.510904367098302
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25902,130,0.79 [0.52-1.20],0.2686875179029971
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25840,68,0.78 [0.44-1.38],0.3863825441890327
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Memory loss,27433,99,0.88 [0.55-1.42],0.6017944752091767
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,26783,527,0.85 [0.69-1.04],0.1132206842034976
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27958,473,0.86 [0.69-1.06],0.1584724014927956
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,19232,122,1.05 [0.69-1.59],0.8258474192556531
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27850,145,0.74 [0.50-1.10],0.1345000801145848
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27202,1430,0.87 [0.77-0.98],0.0234705325305497
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,26415,3901,0.93 [0.86-1.00],0.0619781846126147
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27703,162,0.94 [0.65-1.35],0.7297631758462593
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26209,437,0.70 [0.55-0.88],0.0022632757134869
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28019,240,1.11 [0.83-1.47],0.4755854794420213
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22597,677,1.04 [0.87-1.24],0.6657632552042398
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27505,69,0.84 [0.48-1.49],0.5556845989276755
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27561,125,0.67 [0.43-1.03],0.0672693298696521
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27689,189,1.30 [0.96-1.77],0.0914983632113164
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25870,98,1.29 [0.84-1.97],0.2432271656862342
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,26333,77,0.88 [0.52-1.51],0.6452738750617555
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,27953,517,0.94 [0.77-1.15],0.5207493420246169
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,26676,420,0.88 [0.70-1.11],0.2755325649437473
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,28052,321,0.80 [0.61-1.04],0.0984956437243817
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27520,84,0.85 [0.51-1.42],0.5424618361156932
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,28076,106,0.89 [0.56-1.39],0.5997815549758119
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,27893,332,0.89 [0.69-1.14],0.3588711713134778
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27819,40,0.31 [0.14-0.70],0.0048822898056853
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28067,151,1.04 [0.72-1.50],0.8420099069347844
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25841,69,1.06 [0.62-1.82],0.8326778845259422
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28077,369,1.14 [0.90-1.44],0.2721631094059113
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27518,101,1.32 [0.87-2.01],0.1954653431160465
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27477,112,1.28 [0.85-1.91],0.2384272651991665
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27599,495,0.89 [0.72-1.10],0.2656983841027898
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27928,175,1.42 [1.05-1.92],0.024124315696626
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26939,63,1.06 [0.60-1.86],0.8454715896048337
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26930,54,1.34 [0.76-2.36],0.3181814199680158
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27952,61,0.89 [0.49-1.62],0.7076725717701224
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27784,170,0.81 [0.56-1.18],0.2761157692107789
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1738,37,1.07 [0.55-2.09],0.8343059535197426
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2090,72,1.56 [1.04-2.36],0.032316333466031
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27458,93,0.94 [0.59-1.52],0.8137763903039865
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27894,1082,1.22 [1.07-1.39],0.0034868100887097
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27646,770,1.02 [0.87-1.20],0.8208991736147222
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27179,303,0.75 [0.57-1.00],0.0462198921993845
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27982,878,0.97 [0.83-1.14],0.7186454773141495
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28060,71,0.48 [0.27-0.88],0.0177086929847456
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27902,798,0.94 [0.80-1.11],0.4643077681713988
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28029,415,0.89 [0.70-1.12],0.3134612498035741
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27979,212,1.46 [1.10-1.94],0.0086387532194991
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26917,41,0.82 [0.39-1.72],0.5932200824538103
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26923,47,0.55 [0.26-1.15],0.1119858008669311
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26942,66,0.52 [0.28-0.96],0.0369418274436033
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27988,744,1.16 [0.98-1.36],0.0794192324584173
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27434,190,0.90 [0.64-1.26],0.5299962658577508
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27174,70,0.93 [0.53-1.62],0.7982115033524485
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27718,104,0.91 [0.57-1.43],0.6714856318263893
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27934,320,0.89 [0.68-1.16],0.3739130461736659
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27320,216,1.00 [0.74-1.37],0.9794864090511446
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27906,139,1.39 [0.97-1.98],0.0712222573145601
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27733,489,1.20 [0.98-1.46],0.075414793386992
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27520,155,1.04 [0.73-1.50],0.8259326956956283
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26235,2571,1.03 [0.94-1.13],0.4652941616952597
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27893,279,0.87 [0.65-1.15],0.3322569869422123
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28051,159,1.16 [0.82-1.65],0.3973627885661633
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27279,403,1.09 [0.87-1.36],0.4565850880290817
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27678,64,0.47 [0.25-0.89],0.0200587725583555
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28045,56,0.48 [0.25-0.95],0.0339749250106698
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26969,93,1.22 [0.78-1.91],0.3844204427794143
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27035,159,0.96 [0.67-1.38],0.8211707663098844
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26920,108,1.24 [0.82-1.89],0.3080548913667781
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27177,73,1.23 [0.74-2.04],0.4179761695007786
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26874,62,1.70 [1.04-2.78],0.033982828342771
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27367,123,1.04 [0.69-1.57],0.8512203588993184
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27428,184,1.18 [0.85-1.64],0.3089609800277232
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27013,137,1.30 [0.90-1.87],0.1572629934498383
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26912,100,1.01 [0.64-1.59],0.9673707598994004
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26888,76,1.11 [0.66-1.87],0.6930158197700962
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25811,2147,1.05 [0.95-1.16],0.3652831105049839
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26962,86,0.80 [0.48-1.35],0.4041910290744175
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27804,439,1.07 [0.86-1.32],0.5579529753533793
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27414,49,1.29 [0.70-2.39],0.4093490935612044
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27538,173,1.41 [1.04-1.93],0.0294353888849443
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27829,117,1.17 [0.78-1.75],0.459573752505978
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28029,120,1.19 [0.80-1.77],0.3997566969687065
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27947,147,0.82 [0.56-1.20],0.3063040142261919
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27781,69,0.79 [0.44-1.41],0.4272925938086499
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27784,72,1.04 [0.61-1.77],0.8809390265749129
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27974,836,0.94 [0.80-1.10],0.4545681410737003
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27710,572,1.04 [0.86-1.26],0.6857819290004235
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27263,125,0.67 [0.43-1.03],0.0686744246773491
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27226,88,1.11 [0.69-1.78],0.6619387697086017
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27800,88,0.78 [0.47-1.29],0.3273557816466921
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27949,237,0.98 [0.73-1.31],0.8916516999166196
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27777,65,1.33 [0.79-2.24],0.2756806805073689
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza,26312,131,1.52 [1.08-2.15],0.0175583423225629
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26310,129,1.49 [1.05-2.12],0.025746593917232
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19948,129,1.23 [0.83-1.81],0.2972798093801548
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27918,294,0.78 [0.59-1.03],0.0764132282012941
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21742,2117,1.02 [0.92-1.12],0.7413986449229024
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21909,2090,0.99 [0.89-1.10],0.8472031166316845
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27648,128,1.19 [0.81-1.75],0.3630166277936876
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26249,68,0.98 [0.56-1.70],0.9380106853911856
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,24274,419,1.09 [0.87-1.36],0.4538477320947773
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23928,73,0.63 [0.35-1.13],0.1194966957155938
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26893,3038,1.07 [0.99-1.16],0.087774910596029
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26766,62,0.68 [0.37-1.27],0.2240579976575712
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26854,150,0.99 [0.68-1.44],0.9612549222860016
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27898,1087,1.18 [1.04-1.35],0.0114170092635985
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26779,75,0.59 [0.33-1.04],0.0659304455559609
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25943,5286,1.10 [1.03-1.17],0.0024483735180274
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27043,339,0.88 [0.68-1.13],0.3012104538528067
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,27137,326,1.26 [1.00-1.59],0.0458177619252481
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Emphysema,24137,282,1.11 [0.85-1.44],0.4512807651756101
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26404,236,0.92 [0.68-1.25],0.5835132754366015
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27879,1698,1.27 [1.15-1.41],4.61399859459218e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26445,277,1.03 [0.79-1.36],0.8165736332518484
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Later onset COPD,27138,761,1.16 [0.99-1.37],0.0606685891995355
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28069,232,1.14 [0.85-1.52],0.3806215171934182
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,26774,70,0.92 [0.53-1.60],0.7709109436138286
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27846,943,1.32 [1.16-1.52],5.138013407167019e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27883,1796,1.28 [1.16-1.42],9.87848884356448e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27508,804,0.87 [0.74-1.02],0.0891544837354291
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,26124,37,1.10 [0.53-2.29],0.8043809660222077
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27996,353,1.18 [0.94-1.49],0.1492284920784813
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27985,1211,1.21 [1.07-1.37],0.0022004304756748
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,26959,872,1.45 [1.26-1.67],1.319298727847103e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural plaque,26133,46,1.05 [0.55-2.02],0.8841447156674835
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27637,1456,1.30 [1.16-1.45],2.9485042328655143e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28038,201,1.12 [0.82-1.52],0.4941525364135823
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumothorax,26181,94,1.23 [0.79-1.93],0.3607491330551488
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pollen allergy,28044,246,0.73 [0.53-0.99],0.0401005856098241
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27707,64,1.60 [0.98-2.60],0.05786288757964
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19872,53,2.00 [1.23-3.27],0.0053580453489596
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27821,918,1.33 [1.16-1.53],3.93401089388974e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26998,294,0.77 [0.58-1.02],0.0672674223495122
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,26400,219,1.04 [0.77-1.41],0.7786868569813887
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27658,173,0.95 [0.67-1.34],0.7547022474007373
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13562,110,1.11 [0.72-1.71],0.6421099926124998
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,20021,39,1.23 [0.62-2.44],0.5545013794366228
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,27888,148,0.78 [0.53-1.15],0.2141296870292018
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute gastritis,21062,88,0.77 [0.46-1.29],0.3251163309047837
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25717,166,0.97 [0.68-1.39],0.8809798510594152
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,27491,87,1.20 [0.76-1.90],0.4287140508204999
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27177,34,3.31 [2.10-5.21],2.466517262283492e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,21319,345,0.95 [0.74-1.22],0.7133759326514761
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25631,80,1.17 [0.72-1.89],0.5288004020723204
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27638,80,1.17 [0.73-1.90],0.5129907681725068
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,25743,192,0.76 [0.54-1.07],0.1112512303927411
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,26765,1214,0.83 [0.72-0.95],0.0057139962859228
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,21325,351,0.99 [0.78-1.27],0.9651232089142994
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25594,43,1.19 [0.61-2.30],0.6154211672287502
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27991,72,4.49 [3.42-5.91],5.9391636696865526e-27
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,26481,156,0.64 [0.43-0.95],0.0252526445035498
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,26141,116,1.38 [0.94-2.03],0.098681875830061
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27934,152,1.04 [0.73-1.50],0.81967948707487
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,27723,1769,1.06 [0.95-1.18],0.2679075185228985
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,26119,94,0.89 [0.55-1.44],0.6442508930567764
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27708,70,1.06 [0.62-1.81],0.8283755520271078
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26123,98,1.11 [0.71-1.73],0.6461932306743721
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,27229,234,0.95 [0.70-1.27],0.7106029842538086
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26412,2519,0.81 [0.73-0.89],7.977313152398938e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,27931,191,0.64 [0.45-0.92],0.0141382065989223
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,27972,829,1.44 [1.25-1.66],4.251690690044743e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25722,4748,0.91 [0.85-0.97],0.0060384843145917
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27597,602,0.92 [0.76-1.11],0.3728277275455586
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27953,549,0.99 [0.82-1.20],0.9306392671608192
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27116,121,0.94 [0.62-1.42],0.7581589467115075
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26960,65,0.79 [0.44-1.42],0.4268892646084816
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27767,1442,0.96 [0.85-1.08],0.4669947659121527
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,26971,114,0.79 [0.51-1.24],0.3034922484789385
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27181,1630,0.87 [0.78-0.98],0.0210821395523676
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23265,3283,0.89 [0.82-0.96],0.0043706463284005
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,21106,132,1.26 [0.86-1.84],0.2309165365651063
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28024,111,1.21 [0.80-1.82],0.3721663952979164
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27971,65,0.92 [0.52-1.61],0.7612107916580089
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27237,94,3.63 [2.77-4.77],1.5629886513657262e-20
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20096,114,1.21 [0.81-1.80],0.3630921425556439
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21651,677,0.75 [0.63-0.91],0.0030376051049643
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,21327,353,0.93 [0.73-1.20],0.5916337522580084
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23841,2867,0.80 [0.73-0.87],7.259436002821435e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21453,479,0.94 [0.76-1.16],0.5750993160199309
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21966,8669,0.94 [0.89-0.98],0.0101074444274677
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,27490,1165,0.96 [0.84-1.10],0.553849042112844
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27058,63,0.72 [0.39-1.33],0.2947173039576702
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20975,1295,0.95 [0.83-1.08],0.4099054268801875
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27183,40,2.67 [1.60-4.45],0.0001651451930343
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,26856,2963,0.84 [0.77-0.92],0.0001299435136113
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,27982,60,0.93 [0.52-1.67],0.807242696283428
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,20048,66,0.66 [0.36-1.22],0.1828457957694375
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,24062,169,1.09 [0.77-1.54],0.6215237371312241
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,20087,105,1.09 [0.70-1.70],0.6974956562991712
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26507,182,0.68 [0.47-0.98],0.0373695527227456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20822,840,0.95 [0.81-1.11],0.5187428380280102
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28061,367,1.26 [1.01-1.56],0.038660126336644
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26863,838,1.00 [0.86-1.17],0.9914165046584932
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27155,1130,1.02 [0.89-1.16],0.8279452740687755
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21138,164,0.82 [0.57-1.20],0.3115710676147285
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,21554,580,0.85 [0.69-1.03],0.099477779309642
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28029,161,1.07 [0.75-1.53],0.6985460030713821
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23953,60,0.63 [0.34-1.19],0.1571931400064274
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21284,1302,1.00 [0.88-1.13],0.96362218005473
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25858,307,0.91 [0.70-1.19],0.5050060127598992
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25746,195,0.74 [0.53-1.05],0.0893156283080555
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21603,1621,1.10 [0.99-1.23],0.0862418681665588
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,25847,5865,0.95 [0.89-1.01],0.0766462097890817
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26962,235,0.97 [0.72-1.31],0.8362407360140075
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,27840,697,1.47 [1.26-1.71],8.921827688002276e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21568,594,0.95 [0.79-1.15],0.6099332668709319
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25711,160,0.98 [0.68-1.42],0.919394746772167
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27890,486,1.02 [0.83-1.24],0.8828771597072456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22083,1109,0.96 [0.84-1.11],0.6102110539529522
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27509,1184,0.95 [0.83-1.09],0.4735599910631186
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27192,197,0.98 [0.71-1.36],0.9112604196870936
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21807,1825,1.04 [0.93-1.15],0.5026849569104253
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23141,2167,0.96 [0.87-1.06],0.3819365018767071
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27243,100,2.99 [2.24-3.99],7.915059383725658e-14
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27020,995,1.02 [0.89-1.18],0.7360873058661284
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20320,338,0.94 [0.73-1.21],0.610118448647164
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27960,75,0.96 [0.57-1.63],0.8920157613434616
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20489,507,0.93 [0.76-1.15],0.5104762830919218
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26460,135,1.28 [0.89-1.84],0.1861088783598886
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28069,71,0.88 [0.51-1.53],0.646196583326894
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26997,130,0.74 [0.49-1.13],0.1639180106986723
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Toxic colitis,26093,68,0.87 [0.49-1.54],0.6283818941425733
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21211,237,0.76 [0.56-1.04],0.0895752758186849
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26198,173,1.03 [0.73-1.45],0.8643488394934702
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26167,142,1.06 [0.73-1.55],0.7590513497401641
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,24066,173,1.44 [1.07-1.94],0.01722846175627
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20176,194,1.37 [1.01-1.85],0.0401718443587457
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,24152,259,0.94 [0.70-1.24],0.6492603716788554
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Volvulus,20069,87,0.71 [0.42-1.20],0.2025450596637758
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27987,266,1.06 [0.80-1.40],0.6977422276851991
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27746,79,1.16 [0.72-1.88],0.5348056356189701
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25959,225,0.96 [0.71-1.30],0.7894903560034279
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27531,648,1.30 [1.10-1.53],0.0017593323760681
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27032,149,1.09 [0.76-1.57],0.6244928078902973
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26082,348,1.17 [0.92-1.48],0.2003091808092482
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27753,288,1.30 [1.02-1.67],0.0361878365471116
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27962,497,1.26 [1.04-1.52],0.017608001639275
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27517,52,1.57 [0.92-2.67],0.095602856627432
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26431,3252,1.06 [0.98-1.15],0.1382812621104613
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27615,493,0.94 [0.76-1.15],0.5320969201616406
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27461,339,0.96 [0.75-1.23],0.7369207375474409
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27750,867,1.23 [1.06-1.42],0.0049673052202828
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28052,79,0.65 [0.37-1.13],0.1260264958865704
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25825,91,0.38 [0.22-0.64],0.0003236863814835
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27170,48,0.65 [0.32-1.30],0.2202071403568943
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27738,273,1.33 [1.03-1.72],0.026675911371933
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26161,427,1.10 [0.88-1.36],0.404263813214318
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25782,48,1.14 [0.60-2.16],0.6863968549208952
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27969,85,1.44 [0.93-2.23],0.1017127762475864
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27045,162,1.22 [0.87-1.70],0.2469798725331084
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27838,171,0.98 [0.69-1.38],0.899094173809125
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27523,58,0.68 [0.36-1.30],0.2418884229340056
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25802,68,1.34 [0.80-2.24],0.2679392385484178
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27369,1635,1.07 [0.96-1.19],0.2486038073835715
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26197,463,1.17 [0.96-1.44],0.1249388519656646
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25787,53,0.99 [0.53-1.86],0.9752638014394824
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27987,320,0.85 [0.65-1.10],0.2087182022953513
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27550,85,1.41 [0.90-2.20],0.134154354782029
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27912,245,0.91 [0.68-1.22],0.5298556276536038
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28024,303,1.10 [0.85-1.42],0.4779225634403521
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25898,164,0.89 [0.62-1.28],0.5374263538014612
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26000,266,1.17 [0.89-1.53],0.2677047402090069
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28009,288,1.10 [0.84-1.43],0.4954508477181593
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25942,208,1.70 [1.31-2.21],7.49785082789225e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28040,156,1.18 [0.83-1.66],0.360335658605971
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23948,130,0.65 [0.43-1.00],0.047850284290263
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25494,6556,0.93 [0.88-0.99],0.0175162668086841
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24062,5124,0.91 [0.85-0.97],0.0038724844126423
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23899,81,0.65 [0.38-1.12],0.1219998663271759
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24072,156,0.68 [0.46-1.00],0.0520808895995502
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24133,217,1.01 [0.74-1.38],0.9412061140312472
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27778,117,1.27 [0.86-1.88],0.2361337548316453
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24036,120,1.08 [0.71-1.63],0.7325435390917078
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20348,1410,0.93 [0.82-1.05],0.2472995973971282
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27921,229,0.86 [0.63-1.17],0.3430501701012112
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24539,623,0.76 [0.63-0.92],0.0059929335846143
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23592,8328,0.96 [0.91-1.01],0.1232187560442855
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25159,144,1.02 [0.70-1.49],0.9068387757714056
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23956,138,1.00 [0.68-1.48],0.9811995431633324
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24526,708,0.85 [0.71-1.02],0.075041176146178
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27027,3111,0.90 [0.83-0.98],0.0176226749037118
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24000,182,1.15 [0.83-1.59],0.3987494528750004
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24207,389,0.73 [0.57-0.93],0.0101176576078507
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23993,175,0.92 [0.65-1.31],0.6470370775055689
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27100,111,1.58 [1.09-2.31],0.0168805344310299
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20869,1931,0.88 [0.79-0.97],0.0141095780752013
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19166,228,1.21 [0.92-1.59],0.182538094559659
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28064,225,1.18 [0.89-1.57],0.248052830602616
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19041,103,0.62 [0.38-1.01],0.0539995331411026
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19526,588,0.75 [0.62-0.92],0.0049271661756579
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24159,341,0.88 [0.69-1.14],0.3333546437791477
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19592,654,0.84 [0.69-1.00],0.0560404057558595
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23985,69,0.99 [0.56-1.73],0.9641937433259864
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24649,733,0.78 [0.66-0.93],0.0067291059253177
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24259,343,0.78 [0.61-1.02],0.0666295220568222
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19548,610,0.84 [0.69-1.02],0.0746141521344949
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23914,96,1.12 [0.72-1.76],0.6135262349289715
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23889,71,0.79 [0.45-1.39],0.4155068124406821
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,25065,50,1.41 [0.79-2.49],0.244716956393745
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27586,2571,1.03 [0.94-1.13],0.492118410753607
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26863,1848,1.08 [0.97-1.20],0.1697042792090938
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27872,621,0.92 [0.77-1.11],0.3995775087682588
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22057,3119,0.90 [0.83-0.98],0.0129308843714373
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,19013,75,0.74 [0.42-1.29],0.2858726370663523
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23922,104,1.23 [0.81-1.87],0.3368556447758009
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18982,44,1.86 [1.08-3.21],0.0248987325465677
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19144,206,0.71 [0.50-1.00],0.0485204644171987
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25315,300,0.95 [0.73-1.24],0.7194699141815148
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25615,600,0.86 [0.71-1.05],0.1405550894696249
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28046,117,1.08 [0.71-1.62],0.7255281085152412
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26014,2098,0.89 [0.81-0.99],0.0320153256652033
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23955,137,0.83 [0.55-1.23],0.351182623879092
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19176,238,0.80 [0.59-1.10],0.1650945507976929
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24754,838,0.83 [0.70-0.98],0.025875677198375
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21558,2620,0.87 [0.79-0.95],0.0021917341670912
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27124,135,1.46 [1.03-2.08],0.0337915993480236
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28057,78,1.05 [0.64-1.73],0.8356716993522286
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23901,83,1.17 [0.72-1.87],0.5279701737000002
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25340,1522,0.97 [0.86-1.09],0.6131219306687963
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23903,85,0.95 [0.58-1.57],0.8455276588294216
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20991,2053,0.92 [0.83-1.02],0.1126757495397685
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25154,139,0.80 [0.53-1.20],0.2769003134145992
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23882,64,0.68 [0.37-1.24],0.2096631526229939
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24124,208,0.68 [0.48-0.95],0.0248797640237461
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24426,608,1.20 [1.01-1.43],0.0411616630884394
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27511,522,0.76 [0.62-0.94],0.0118417164909262
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24582,666,1.07 [0.90-1.27],0.4592304284759342
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27887,601,0.96 [0.80-1.16],0.6725362515413562
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28047,70,1.02 [0.59-1.75],0.9462624969619764
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24050,232,0.87 [0.64-1.18],0.3783984262466952
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21544,947,0.96 [0.83-1.12],0.610142997748613
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24505,687,0.94 [0.78-1.11],0.4553020591683576
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23944,126,1.22 [0.83-1.80],0.3102217041971224
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",19016,78,0.99 [0.58-1.67],0.9599858791308244
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21660,2722,0.97 [0.89-1.06],0.5185338910519861
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19802,864,0.84 [0.71-0.98],0.0285502294420834
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27296,307,0.85 [0.65-1.12],0.2592339584781129
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28016,87,1.24 [0.78-1.96],0.3568687774469904
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25710,57,0.99 [0.54-1.79],0.9652245272889798
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,19017,79,1.04 [0.63-1.72],0.8776037305092383
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24031,115,0.70 [0.45-1.11],0.1311093699105124
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19563,625,0.90 [0.75-1.09],0.2891609925738891
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24159,341,1.01 [0.79-1.30],0.9140860718618362
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24209,293,0.91 [0.69-1.19],0.477294794688555
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24202,286,0.81 [0.61-1.07],0.1374792456349477
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21664,87,0.59 [0.34-1.00],0.0509029699691923
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28054,77,0.96 [0.57-1.62],0.8750772105525725
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24477,659,0.97 [0.81-1.16],0.750486537111574
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27152,163,0.65 [0.44-0.95],0.0267361525997822
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26720,2902,0.98 [0.90-1.07],0.6511599423736084
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23977,159,0.76 [0.52-1.12],0.1651906849305808
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24502,586,0.90 [0.74-1.09],0.2721444252878336
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26314,274,0.68 [0.51-0.91],0.010208902262599
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24201,285,0.68 [0.50-0.91],0.0086065755278201
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25727,1811,0.84 [0.75-0.94],0.0024719078645596
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25147,1231,0.83 [0.73-0.95],0.0075947139899527
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23884,66,1.30 [0.77-2.19],0.3244799395252483
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27219,230,0.57 [0.41-0.79],0.0006766084370197
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24026,208,0.93 [0.68-1.28],0.659571337321543
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23948,130,0.76 [0.50-1.16],0.2015140492722779
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18994,56,0.75 [0.39-1.45],0.390674303724869
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26973,1289,1.43 [1.28-1.60],6.92681417475913e-10
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21017,104,0.95 [0.61-1.48],0.8213037774531833
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27363,112,1.11 [0.74-1.69],0.608884590884843
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27911,241,1.55 [1.21-2.00],0.0006551203379227
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27698,28,0.53 [0.21-1.37],0.1912245655252704
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27209,1525,1.27 [1.14-1.42],1.5988965493664222e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27900,81,1.63 [1.07-2.47],0.0234184569819238
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27862,247,1.20 [0.91-1.58],0.1914949763178743
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,24767,258,1.06 [0.80-1.41],0.6682049717504883
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,25738,54,1.52 [0.87-2.66],0.1447338199209461
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27594,343,0.96 [0.75-1.22],0.715148841358977
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21098,185,0.86 [0.61-1.21],0.381233889500834
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21318,405,0.70 [0.55-0.88],0.0019980682368602
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21942,1029,0.69 [0.59-0.80],1.9958475058567267e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21855,5191,1.02 [0.96-1.09],0.5102767689693873
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27884,65,1.01 [0.58-1.78],0.9628560161010892
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25558,218,1.34 [1.00-1.78],0.0461788988181675
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27514,406,1.02 [0.82-1.28],0.8338290717367738
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27599,131,0.94 [0.63-1.39],0.7386651047808263
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21224,311,0.62 [0.47-0.80],0.0003443993551785
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24589,80,0.88 [0.52-1.49],0.6255104249407014
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23419,2506,0.86 [0.78-0.94],0.001447191396279
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21056,143,0.81 [0.54-1.19],0.2797857552569316
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28062,67,0.73 [0.41-1.32],0.2993733420871329
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28066,76,1.34 [0.83-2.16],0.2256973638495588
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26804,2295,1.06 [0.97-1.17],0.2177984096390509
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24996,487,0.99 [0.80-1.22],0.9043004152146552
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27371,120,1.01 [0.67-1.53],0.9436983524102062
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28012,397,1.07 [0.86-1.34],0.5271997439714124
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28014,93,0.63 [0.38-1.05],0.0764862529838804
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26478,1969,1.08 [0.98-1.19],0.1416131232471334
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27317,209,0.98 [0.71-1.33],0.8757300857775352
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21071,158,0.97 [0.67-1.39],0.8550366061565369
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21290,377,0.82 [0.64-1.04],0.0991559332166032
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21024,111,1.33 [0.89-1.97],0.1648765285980515
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21124,211,1.14 [0.84-1.54],0.3981397439581232
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25611,271,1.16 [0.89-1.52],0.2734087970895602
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27743,128,0.90 [0.60-1.35],0.6045421786437668
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21227,314,0.98 [0.76-1.27],0.8959659921775177
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21022,109,0.45 [0.28-0.72],0.0007854512096897
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21573,660,0.94 [0.78-1.12],0.4668599357483042
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21077,164,0.94 [0.65-1.35],0.7362805736924907
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21520,607,1.00 [0.83-1.20],0.969319930336356
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27857,38,0.84 [0.39-1.80],0.656015214184664
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27875,2535,1.25 [1.15-1.37],1.682727677867378e-07
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25509,169,1.10 [0.78-1.55],0.6037390714851227
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25788,104,1.94 [1.36-2.75],0.0002248593850393
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27705,35,1.01 [0.48-2.16],0.9724721252908344
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24657,148,1.12 [0.77-1.62],0.556625131842027
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27945,275,1.37 [1.07-1.75],0.0137956675801495
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21057,144,1.42 [1.01-1.98],0.0415352101917121
